Cargando…
Respiratory Syncytial Virus: Current Progress in Vaccine Development
Respiratory syncytial virus (RSV) is the etiological agent for a serious lower respiratory tract disease responsible for close to 200,000 annual deaths worldwide. The first infection is generally most severe, while re-infections usually associate with a milder disease. This observation and the findi...
Autores principales: | Rudraraju, Rajeev, Jones, Bart G., Sealy, Robert, Surman, Sherri L., Hurwitz, Julia L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640515/ https://www.ncbi.nlm.nih.gov/pubmed/23385470 http://dx.doi.org/10.3390/v5020577 |
Ejemplares similares
-
Respiratory Tract Epithelial Cells Express Retinaldehyde Dehydrogenase ALDH1A and Enhance IgA Production by Stimulated B Cells in the Presence of Vitamin A
por: Rudraraju, Rajeev, et al.
Publicado: (2014) -
Will Attention by Vaccine Developers to the Host’s Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?
por: Sealy, Robert E., et al.
Publicado: (2019) -
Respiratory Syncytial Virus Human Experimental Infection Model: Provenance, Production, and Sequence of Low-Passaged Memphis-37 Challenge Virus
por: Kim, Young-In, et al.
Publicado: (2014) -
Might Routine Vitamin A Monitoring in Cystic Fibrosis Patients Reduce Virus-Mediated Lung Pathology?
por: Sealy, Robert E., et al.
Publicado: (2021) -
Nuclear Receptors, Ligands and the Mammalian B Cell
por: Jones, Bart G., et al.
Publicado: (2020)